Abstract
Anger and hazardous driving were explored in two studies for their possible explanatory role in the low cholesterol-violent mortality association. In Study 1, we obtained fasting blood samples and indices of anger and driving habits from 102 healthy young adults. Among men (but not women), lower low-density lipoprotein (LDL) cholesterol levels were associated with significantly higher anger (r = -.41, p < .01) and unsafe driving habits (r = -.30, p < .05), and although total cholesterol levels were correlated in the predicted direction, these were not significant. In Study 2,78 healthy young men completed the same measures, and this time, both lower total and LDL-cholesterol were significantly related to increased anger and dangerous driving. Implications of these Findings are discussed as are possible avenues for future research. Further scrutiny of the components of serum cholesterol and their relation to psychological factors may aid us in better understanding the reasons why men are at increased risk for hazardous behavior and violent death.
Similar content being viewed by others
References
Arntzenius, A. C., Kromhout, D., Barth, J. D., Reiber, H. H. C., Bruschke, A. V. G., Buis, B., vanGent, C. M., Kempen-Voogd, N., Strikwerda, S., & van der Velde, E. A. (1985), Diet, lipoproteins, and the progress of coronary atherosclerosis: The Leiden Intervention Trial. New England Journal of Medicine, 312, 805–811.
Blankenhorn, D. H., Nessim, S. A., Johnson, R. L., Sonmarco, M. E., Azen, S. P., & Cashin-Hemphill, L. (1987). Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. Journal of the American Medical Association, 257, 3233–3240.
Browner, W. S., Westenhouse, J., & Tice, J. A. (1991). What if Americans ate less fat? A quantitative estimate of the effect on mortality. Journal of the American Medical Association, 265, 3285–3291.
Buchwald, H., Varco, R. I., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hanson, B. J., Tuna, N., Kamegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., Chalmers, T. C., & POSCH Group. (1990). Effects of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. New England Journal of Medicine, 323, 946–955.
Canadian Consensus Conference on Cholesterol. (1988). Final Report. Canadian Medical Association Journal, 139(Suppl. 11), 1–8.
Chen, Z., Peto, R., Collins, R., MacMahon, S., Lu, J., & Li, W. (1991). Serum cholesterol and coronary heart disease in a population with low cholesterol concentrations. British Medical Journal, 303, 276–282.
Connelly, P. W., MacLean, D. R., Horlick, L., O’Connor, B., Petrasovits, A., Little, A., & The Canadian Heart Health Survey Research Group. (1992). Plasma lipids and lipoproteins and prevalence of risk for coronary heart disease in Canadian adults. Canadian Medical Association Journal, 146(Suppl. 1), 9–19.
Conroy, R. M. (1993). Low cholesterol and violent death: The evidence, the gaps, the theory and the practical implications. Irish Journal of Psychological Medicine, 10, 67–70.
Cummings, P., & Psaty, B. M. (1994). The association between cholesterol and death from injury. Annuls of Internal Medicine, 120, 848–855.
Dayton, S., Pearce, M. L., Hashimoto, S., Dixon, W. J., & Tomiyasu, U. (1969). A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation, 39–40(Suppl.), 1–63.
Draeger, B., Wahlefeld, A. W., & Ziegcnhorn, J. (1955). Cholesterol: HDL-cholesterol. In J. Bergmeyer & M. Grassl (Eds.), Methods of enzymatic analysis: Vol. VIII: Metabolites 3: Lipids, amino acids and related compounds (3rd ed., pp. 148–154). Deerfield Beach, FL: Verlag Chemie.
Engelberg, H. (1992). Low serum cholesterol and suicide. Lancet, 339, 727–729.
Farchi, G., Menotti, A., & Conti, S. (1987). Coronary risk factors and survival probability from coronary and other causes of death. American Journal of Epidemiology, 126, 400–408.
Fowkes, F. G. R., Leng, G. C., Donnan, P. T., Dearym, I. J., Riemersma, R. A., & Housley, E. (1992). Serum cholesterol, triglycerides, and aggression in the general population. Lancet, 340, 995–998.
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttenen, J. K., Kaiteniemi, P., Koshkinen, P., Manninen, V., Maenpaa, H., Malkonen, M., Mantarri, M., Norola, S., Pastemack, A., Pikkarainen, J., Romo, M., Sjoblom, T., & Nikkila, E. A. (1987). Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. New England Journal of Medicine, 317, 1237–1244.
Friedwald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentrations of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.
Griffin, K. W., & Weidner, G. (1994). Cholesterol-lowering and psychological well-being. Compressive Therapy, 20, 518–522.
Guicheney, P., Devynck, M. A., Cloix, J. F., Pemollet, M. G., Grichois, M. L., & Meyer, P. (1988). Platelet 5-HT content and uptake in essential hypertension. Role of endogenous digitalis-like factors and plasma cholesterol. Journal of Hypertension, 6, 115–126.
Harris, T., Feldman, J. J., Kleinman, J. C., Ettinger, W. H., Jr., Makuc, D. M., & Schatzkin, A. G. (1992). The low cholesterol-mortality association in a national cohort. Journal of Clinical Epidemiology, 45, 595–601.
Hettler, B. (1978). A lifestyle improvement program that pays for itself. In Proceedings of the fourteenth meeting of the Society of Prospective Medicine (pp. 13–17). Bethesda, MD.
Hillbrand, M., Spitz, R. T., & Foster, H. G. (1995). Serum cholesterol and aggression in hospitalized male forensic patients. Journal of Behavioral Medicine, 18, 33–43.
Hulley, S. B., Walsh, J. B. M., & Newman, T. B. (1992). Health policy on blood cholesterol: Time to change directions. Circulation, 86, 1026–1029.
Jacobs, D., Blackburn, H., Higgens, M., Reed, D., Iso, H., McMillan, G., Nealon, J., Nelson, J., Potter, J., Rifkind, B., Rossouw, J., Shekelle, R., & Yusuf, S. (1992). Report of the conference on low blood cholesterol: Mortality associations. Circulation, 86, 1046–1060.
Kaplan, J. R., Manuck, S. B., & Shivcly, C. (1991). The effects of fat and cholesterol on social behavior in monkeys. Psychosomatic Medicine, 53, 634–642.
LaRosa, J. C., Hunninghake, D., Bush, D., Criqui, M. H., Getz, G. S., Gotto, A. M., Jr., Grundy, S. M., Rakita, L., Robertson, R. M., Weisfeldt, M. L., Cleeman, J. I., & Writing Group (1990). The cholesterol facts: A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation, 81, 1721–1733.
Lindberg, G., Rastam, L., Gullberg, B., & Gunnar, G. A. (1992). Low serum cholesterol concentration and short-term mortality from injuries in men and women. British Medical Journal, 305, 277–279.
Lipid Research Clinics Program. (1984). The lipid research clinics coronary primary prevention trial’s results—I. Reduction in the incidence of coronary heart disease. Journal of the American Medical Association, 251, 351–364.
Lundberg, V., Hedman, M., Metin, B., & Frankenhaeuser, M. (1989). Type A behavior in healthy males and females as related to physiological reactivity and blood lipids. Psychosomatic Medicine, 51, 113–122.
Mason, R. P., Herbette, L. G., & Silverman, D. I. (1991). Can altering serum cholesterol affect neurologic function? Journal of Molecular Cellular Cardiology, 23, 1339–1342.
Muldoon, M. R., & Manuck, S. B. (1992). Health through cholesterol reduction: Are there unforeseen risks? Annals of Behavioral Medicine, 14, 101–108.
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1990). Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. British Medical Journal, 301, 309–314.
Nagele, U., Wahlefeld, A. W., & Ziegenhom, J. (1985), Triglycerides: Colorimetric methods. In J. Bergmeyer & M. Grassl (Eds.), Methods of enzymatic analysis: Vol. VIII: Metabolites 3: Lipids, amino acids and related compounds (3rd ed., pp. 12–18). Deerfield Beach, FL: Verlag Chemie.
National Cholesterol Education Program. (1988). Report of expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Archives of Internal Medicine, 148, 36–69.
National Wellness Institute. (1992). The Lifestyle Assessment Questionnaire. Stevens Point, WI: Author.
Nova Scotia Department of Health and Department of National Health and Welfare. (1987). Report of the Nova Scotia Heart Health Survey. Ottawa: Author.
Oliver, M. F. (1988). Reducing cholesterol does not reduce mortality. Journal of the American College of Cardiology, 12, 814–817.
Palombi, B. J. (1992). Psychometric properties of wellness instruments. Journal of Counselling and Development, 71, 221–225.
Pekkanen, J., Nissinen, A., Punsar, S., & Karvonen, M. (1989), Serum cholesterol and risk of accidental or violent death in a 25-year follow-up. Archives of Internal Medicine, 149, 1589–1591.
Preston, M. R., Herbette, L., & Silverman, D. (1991). Can altering serum cholesterol affect neurologic function? Journal of Molecular Cell Cardiology, 23, 1339–1342.
Scandinavian Simvastatin Survival Study Group. (1994). Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S). The Lancet, 344, 1383–1389.
Siedel, J., Rollinger, W., Roschlau, P., & Ziegenhom, J. (1985). Cholesterol: Total cholesterol, end-point and kinetic method, In J. Bergmeyer & M. Grassl (Eds.), Methods of enzymatic analysis: Vol, VIII: Metabolites 3: Lipids, amino acids and related compounds (3rd ed., pp. 139–148). Deerfield Beach, FL: Verlag Chemie.
Siegel, J. M. (1985). The measurement of anger as a multidimensional construct. In M. A. Chesney & R. H. Rosenman (Eds.), Anger and hostility in cardiovascular and behavioral disorders (pp. 59–83). Washington. DC: Hemisphere Publishing Corporation.
Siegel, J. M. (1986). The Multidimensional Anger Inventory. Journal of Personality and Social Psychology, 51, 191–200.
Smith, G. D., Shipley, M. J., Marmot, M. G., & Rose, G. (1992). Plasma cholesterol concentration and mortality: The Whitehall study. Journal of the American Medical Association, 267, 71–76.
Virkkunen, M. (1979). Serum cholesterol in antisocial personality. Neuropsychobiology, 5, 27–30.
Virkkunen, M. (1983). Serum cholesterol levels in homicidal offenders: A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology, 10, 65–69.
Virkkunen, M., Horrobin, D. F., Jenkins, D. K., & Manku, M. S. (1987). Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders. Biological Psychiatry, 22, 1087–1096.
Virkkunen, M., & Penttinen, H.(1984). Serum cholesterol in aggressive conduct disorder: A preliminary study. Biological Psychiatry, 19, 435–439.
Weidner, G., Connor, S. J., Hollis, J. R. & Connor, W. E. (1992). Improvements in hostility and depression in relation to dietary change and cholesterol lowering: The Family Heart study. Annals of Internal Medicine, 117, 820–823.
Weidner, G., Sexton, G., McLellarn, R., Connor, S. L., & Matarazzo, J. D. (1987). The role of Type A behavior and hostility in an elevation of plasma lipids in adult women and men. Psychosomatic Medicine, 49, 136–145.
Wysowski, D. K., & Gross, T. P. (1990). Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Archives of Internal Medicine, 150, 2169–2172.
Author information
Authors and Affiliations
Additional information
This research was supported by a grant from the Heart and Stroke Foundation of Nova Scotia and the Nova Scotia Medical Research Foundation. We thank Sandra McFadyen and Michael MacGregor for data collection, and Sandra McFadyen and William F, Chaplin for comments on an earlier version of this article.
Rights and permissions
About this article
Cite this article
Davidson, K.W., Reddy, S.S.K., McGrath, P. et al. Is there an association among low untreated serum lipid levels, anger, and hazardous driving?. Int. J. Behav. Med. 3, 321–336 (1996). https://doi.org/10.1207/s15327558ijbm0304_3
Issue Date:
DOI: https://doi.org/10.1207/s15327558ijbm0304_3